Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient with MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition

Lei Deng; Lesli A. Kiedrowski; Elizabeth Ravera; Haiying Cheng; Balazs Halmos

doi:10.1016/j.jtho.2018.04.007

Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient with MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition

Lei Deng
, Lesli A. Kiedrowski
, Elizabeth Ravera
, Haiying Cheng
, Balazs Halmos

Oncology

Research output: Contribution to journal › Letter › peer-review

50 Scopus citations

Original language	English (US)
Pages (from-to)	e169-e172
Journal	Journal of Thoracic Oncology
Volume	13
Issue number	9
DOIs	https://doi.org/10.1016/j.jtho.2018.04.007
State	Published - Sep 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Oncology
Pulmonary and Respiratory Medicine

Access to Document

10.1016/j.jtho.2018.04.007

Cite this

Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient with MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition. / Deng, Lei; Kiedrowski, Lesli A.; Ravera, Elizabeth et al.
In: Journal of Thoracic Oncology, Vol. 13, No. 9, 09.2018, p. e169-e172.

Research output: Contribution to journal › Letter › peer-review

@article{842b3d19fbd24f55a288627ca4737d3e,

title = "Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient with MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition",

author = "Lei Deng and Kiedrowski, \{Lesli A.\} and Elizabeth Ravera and Haiying Cheng and Balazs Halmos",

year = "2018",

month = sep,

doi = "10.1016/j.jtho.2018.04.007",

language = "English (US)",

volume = "13",

pages = "e169--e172",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "9",

}

TY - JOUR

T1 - Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient with MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition

AU - Deng, Lei

AU - Kiedrowski, Lesli A.

AU - Ravera, Elizabeth

AU - Cheng, Haiying

AU - Halmos, Balazs

PY - 2018/9

Y1 - 2018/9

UR - https://www.scopus.com/pages/publications/85052299914

UR - https://www.scopus.com/pages/publications/85052299914#tab=citedBy

U2 - 10.1016/j.jtho.2018.04.007

DO - 10.1016/j.jtho.2018.04.007

M3 - Letter

C2 - 30166014

AN - SCOPUS:85052299914

SN - 1556-0864

VL - 13

SP - e169-e172

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 9

ER -

Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient with MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this